Adar Poonawalla's Serum Institute to invest 240 mn pounds to expand vaccine business in UK
Serum Institute of India (SII), which is known globally for its vaccine production capacity is among 20 Indian companies across sectors (healthcare, biotech and software services) to announce massive investment plans in the UK
BusinessToday.In | May 4, 2021 | Updated 13:05 IST
Adar Poonawalla
Adar Poonawalla-helmed Serum Institute will pump in 240 million British pounds to expand its vaccine business and setting up a new sales office in the UK. This investment is part of plans for 1 billion British pound India-UK Enhanced Trade Partnership, which will create approximately 6,500 jobs in the UK, Downing Street announced.